Detalus Advisors, LLC Abb Vie Inc. Transaction History

Detalus Advisors, LLC

$287 Million
Q3 2024

A detailed history of Detalus Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Detalus Advisors, LLC holds 14,598 shares of ABBV stock, worth $2.56 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

14,598

Previous 14,554 0.3%

Holding current value

$2.56 Million

Previous $2.5 Million 15.46%

% of portfolio

1.01%

Previous 0.89%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $7,208 - $8,770	44 Added 0.3%	14,598 $2.88 Million
Q2 2024 Jul 26, 2024	SELL	$154.79 - $180.76 $224,600 - $262,282	-1,451 Reduced 9.07%	14,554 $2.5 Million
Q1 2024 Apr 24, 2024	SELL	$159.82 - $182.1 $19,817 - $22,580	-124 Reduced 0.77%	16,005 $2.91 Million
Q4 2023 Jan 24, 2024	SELL	$137.6 - $154.97 $55,040 - $61,988	-400 Reduced 2.42%	16,129 $2.5 Million
Q3 2023 Oct 26, 2023	SELL	$133.59 - $154.65 $26,718 - $30,930	-200 Reduced 1.2%	16,529 $2.46 Million
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $29,682 - $36,937	224 Added 1.36%	16,729 $2.25 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $143,742 - $165,540	-994 Reduced 5.68%	16,505 $2.63 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $1.91 Million - $2.29 Million	13,785 Added 371.16%	17,499 $2.83 Million
Q3 2022 Nov 04, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 2.62%	3,714 $498,000
Q1 2022 Apr 25, 2022	SELL	$131.98 - $163.75 $316,752 - $393,000	-2,400 Reduced 38.62%	3,814 $618,000
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $9,668 - $12,233	-90 Reduced 1.43%	6,214 $841,000
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $37,240 - $42,273	350 Added 5.88%	6,304 $680,000
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $626,420 - $697,868	5,954 New	5,954 $671,000
Q3 2020 Nov 18, 2020	SELL	$85.91 - $100.83 $212,541 - $249,453	-2,474 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $181,517 - $242,897	2,474 New	2,474 $243,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $156,412 - $237,140	-2,425 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $174,915 - $218,856	2,425 New	2,425 $215,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Abb Vie Inc. Transaction History